Continuous Glucose Monitoring (CGM) systems track glucose levels, every few minutes, 24/7 through a tiny sensor inserted under your skin, either on your belly or arm using an automatic applicator. The sensor measures your interstitial glucose level, which is the glucose found in the fluid between the cells. CGM can be used with or without an insulin pump.
Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to additional algorithms and insights that can inform you of clinically relevant glucose patterns.†
Measures sensor glucose 24/7 and sends alerts when a high or low is detected.
Discreetly view your glucose reading on your smart phone. Get notifications on your smart watch.
Trend arrows provide insight on the direction your glucose is heading, customizable predictive alerts help you take action earlier.
You decide in advance when you want to be alerted between 10-60 minutes in 5 minute increments. Minimum two calibrations per day required.
Available for Apple Devices.
The Sugar.IQ™ assistant supercharges the Guardian™ Connect system’s smarts by giving you a big picture view of your glucose patterns – and the factors that affect them.
A member of our team will reach out to you about your eligibility. If you have questions please contact us at 888-882-8602 (M-F 9AM-6PM CST).
Anytime access to glucose levels and auto uploads to the CareLink™ Connect platform.
Stay connected to your family and friend with automatic text message alerts through a unique care partner app.
We check your insurance and pharmacy benefits for coverage. You choose the one that is best for you.
We have your back. Our 24-hour Technical Support is staffed 24/7.
Our team of dedicated clinicians will help guide you through training and ongoing support, our goal is that you StartRight™.
Peace of mind: we’ll replace your device. See conditions.
No regrets: if you’re not happy with our product, you can return it within 30-days – no questions asked.
† Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to Sugar.IQ™ insights that can inform users of clinically relevant glucose patterns.
‡ Android is a trademark of Google LLC.
Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.
Important Safety Information: Sugar.IQ™ App
The Sugar.IQ™ app (MMT-8100) helps manage diabetes by facilitating the logging and display of meal entries and sensor glucose (SG) data, tracking meal log entries, reporting insights of how meals affect glucose levels, and supporting good choices and trends with motivational messages. The app serves as an additional display for real-time CGM data from the Guardian™ Connect system through the CareLink™ Personal software. It is not intended to provide medical advice and should not be relied upon for such purpose. The app is not intended to replace the real-time display of the CGM data on the Guardian™ Connect app, control any functions of the connecting device, calculate insulin or other drug doses, or modify date or control functions of the Guardian™ Connect system. All therapy decisions should be made by the app user based on blood glucose (BG) measurements obtained from a BG meter. Changes to treatment should only be made in consultation with a healthcare professional (HCP). For complete details, consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.
The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.
Important Safety Information: CareLink™ Software
The CareLink™ software is intended for use as a tool to help manage diabetes. The purpose of the software is to take information transmitted from insulin pumps, glucose meters and continuous glucose monitoring systems, and turn it into CareLink™ reports. The reports provide information that can be used to identify trends and track daily activities—such as carbohydrates consumed, meal times, insulin delivery, and glucose readings. NOTE: CareLink™ report data is intended for use as an adjunct in the management of diabetes only and NOT intended to be relied upon by itself. Patients should consult their healthcare providers familiar with the management of diabetes prior to making changes in treatment. For more details, please consult important safety information. and the appropriate CareLink™ User Guide at http://www.medtronicdiabetes.com/support/download-library/user-guides.
Important Safety Information: i-Port Advance™ Injection Port
i-Port Advance™ injection port is indicated for patients who administer or receive multiple daily subcutaneous injections of physician prescribed medications, including insulin. The device may remain in place for up to 72 hours to accommodate multiple injections without the discomfort of additional needle sticks. i-Port Advance™ injection port may be used on a wide range of patients, including adults and children. For more, please see http://www.medtronicdiabetes.com/important-safety-information.
© Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.